 | Rubius Therapeutics (NASDAQ:RUBY) Given New $40.00 Price Target at HC Wainwright
marketbeat.com - March 22 at 8:57 AM |
 | Should You Take Comfort From Insider Transactions At Rubius Therapeutics, Inc. (NASDAQ:RUBY)?
finance.yahoo.com - April 12 at 5:57 PM |
| Rubius Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of RTX-321 for the Treatment of HPV 16-Positive Cancers
finance.yahoo.com - April 12 at 12:56 PM |
 | Zacks: Analysts Expect Rubius Therapeutics, Inc. (NASDAQ:RUBY) to Post -$0.54 EPS
americanbankingnews.com - April 10 at 8:08 AM |
| Rubius Therapeutics Presents Initial Clinical Results from the Ongoing Phase 1/2 Clinical Trial of RTX-240 in Advanced Solid Tumors at the American Association of Cancer Research Virtual Annual Meeting
finance.yahoo.com - April 9 at 12:00 PM |
| Rubius Therapeutics (NASDAQ:RUBY) Shares Gap Up to $26.50
americanbankingnews.com - April 1 at 12:08 PM |
| Rubius Therapeutics (NASDAQ:RUBY) Shares Up 9.9%
americanbankingnews.com - March 31 at 12:56 PM |
| Rubius Therapeutics Charts A New Path For Hard-To-Treat Cancers
finance.yahoo.com - March 27 at 1:25 PM |
| Rubius Therapeutics (NASDAQ:RUBY) Shares Gap Down to $31.78
americanbankingnews.com - March 26 at 11:40 AM |
| Rubius Therapeutics (NASDAQ:RUBY) Price Target Raised to $40.00 at HC Wainwright
americanbankingnews.com - March 22 at 10:20 AM |
|
| Rubius Therapeutics (NASDAQ:RUBY) PT Raised to $20.00
americanbankingnews.com - March 22 at 10:20 AM |
 | First Week of RUBY November 19th Options Trading
nasdaq.com - March 19 at 7:04 PM |
| Implied Volatility Surging for Rubius Therapeutics (RUBY) Stock Options
finance.yahoo.com - March 17 at 1:34 PM |
| Rubius Therapeutics: Promising Cancer Treatment Data De-Risks Pipeline
finance.yahoo.com - March 17 at 8:34 AM |
| Rubius Therapeutics Prices Upsized Public Offering of Common Stock
finance.yahoo.com - March 17 at 12:39 AM |
| Biotech Stocks To Buy In March 2021? 4 Names To Know
nasdaq.com - March 16 at 2:38 PM |
 | Why Rubius Therapeutics Is Trading Higher Today
msn.com - March 16 at 2:38 PM |
| Notable Monday Option Activity: LLY, RUBY, PENN
nasdaq.com - March 15 at 6:29 PM |
| Rubius Therapeutics Stock Trading Higher On Positive Efficacy, Safety RTX-240 Data In Solid Tumor Study
finance.yahoo.com - March 15 at 6:29 PM |
 | Why Rubius Therapeutics Stock Is Skyrocketing Today
fool.com - March 15 at 6:29 PM |
| Rubius Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - March 15 at 6:29 PM |
 | Rubius Rides Trial Results to Higher Stock Prices
marketwatch.com - March 15 at 1:28 PM |
 | This Cancer Study Is a Gamechanger, and the Stock Practically Doubled
247wallst.com - March 15 at 1:28 PM |
| Rubius Doubles on Progress in Early-Stage Cancer-Drug Trial
finance.yahoo.com - March 15 at 1:28 PM |
| Rubius Stock Flies To Record High After Experimental Cancer Drug Proves Itself
finance.yahoo.com - March 15 at 1:28 PM |
| Rubius Therapeutics Reports Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-240 in Patients with Advanced Solid Tumors, Demonstrating Single-Agent Activity
finance.yahoo.com - March 15 at 7:53 AM |
| Rubius Therapeutics to Present Initial Clinical Results from the Ongoing Phase 1/2 Clinical Trial of RTX-240 in Advanced Solid Tumors at the American Association of Cancer Research Virtual Annual Meeting
finance.yahoo.com - March 10 at 7:33 PM |
 | Rubius Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
markets.businessinsider.com - February 23 at 11:05 AM |
| Rubius Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 18 at 1:04 PM |
| Rubius Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - February 9 at 8:57 AM |
|
| Rubius Therapeutics to Participate in Guggenheim Healthcare Talks | 2021 Oncology Days
finance.yahoo.com - February 3 at 6:39 PM |
| Rubius Therapeutics Provides Operational Update and Outlines 2021 Objectives at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 11 at 5:34 PM |
| Rubius Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
marketwatch.com - January 5 at 1:01 AM |
| Rubius Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 8:01 PM |
| Is Rubius (RUBY) A Good Stock To Buy Now?
finance.yahoo.com - December 11 at 1:16 AM |
 | Rubius Therapeutics to Participate in Evercore ISI 3rd Annual HealthCONx Conference
benzinga.com - November 30 at 5:57 PM |
| Rubius Therapeutics to Participate in Evercore ISI 3rd Annual HealthCONx Conference
finance.yahoo.com - November 30 at 5:57 PM |
| Rubius Therapeutics to Participate in Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 10 at 7:34 PM |
| Rubius Therapeutics Presents Preclinical Data for Lead Red Cell Therapeutic™ Clinical Oncology Program, RTX-240, at the Society for Immunotherapy of Cancer’s Annual Meeting
finance.yahoo.com - November 9 at 1:16 PM |
| Rubius Therapeutics Reports Third Quarter 2020 Financial Results and Strong Execution Across the Pipeline
finance.yahoo.com - November 9 at 1:16 PM |
| Rubius Therapeutics Announces Dosing of First Patient with Relapsed/Refractory Acute Myeloid Leukemia in the Ongoing Phase 1/2 Clinical Trial of RTX-240
finance.yahoo.com - November 5 at 8:40 AM |
| Rubius Therapeutics to Announce Third Quarter 2020 Financial Results
finance.yahoo.com - October 29 at 6:58 PM |
 | Rubius Therapeutics' RTX-321 shows dual mechanism of action in HPV-positive cancers
seekingalpha.com - October 28 at 7:17 AM |
| Rubius Therapeutics Presents Preclinical Data for RTX-321, a Red Cell Therapeutic™ Oncology Product Candidate for HPV-Positive Cancers, Demonstrating its Dual Mechanism of Action
finance.yahoo.com - October 28 at 7:17 AM |
| Rubius Therapeutics Announces Preclinical Data Supporting its Lead Clinical Oncology Program, RTX-240, to be Presented at the Society for Immunotherapy of Cancer’s Annual Meeting
finance.yahoo.com - October 22 at 11:55 PM |
| Are Insiders Buying Rubius Therapeutics, Inc. (NASDAQ:RUBY) Stock?
finance.yahoo.com - October 14 at 6:13 PM |
| Rubius Therapeutics (RUBY) Presents at H.C. Wainwright Annual Global Investment Conference - Slideshow
seekingalpha.com - September 18 at 7:08 PM |
| Rubius Therapeutics EPS beats by $0.03
seekingalpha.com - August 10 at 8:36 AM |
| Rubius Therapeutics Reports Second Quarter 2020 Financial Results and Positive Progress Across Pipeline
finance.yahoo.com - August 10 at 8:36 AM |
| Rubius Therapeutics to Announce Second Quarter 2020 Financial Results
finance.yahoo.com - August 3 at 8:27 PM |
| Did Hedge Funds Drop The Ball On Designer Brands Inc. (DBI)
finance.yahoo.com - August 3 at 3:26 PM |
